Optimise your dental practice workforceNews
Posted by: The Probe 18th December 2020
Despite ever-changing guidelines, many dental professionals have quickly and effectively adapted their practice protocols to better protect themselves and patients from the risk of infection. Of course, due to the very nature of dentistry, clinicians have long practised high standards of infection control to ensure the health and safety of everyone in the practice and beyond. The current health climate has acted as a catalyst for clinicians to adopt an even more proactive approach in minimising the spread of COVID-19 and limiting its impact on the industry and wider society.
As well as donning extra PPE and performing more frequent and thorough disinfection in practice, dental teams have modified their workflows to accommodate recommended fallow time guidance. To support the mitigation of aerosols generated during various dental procedures, clinicians have also switched from using high-energy instruments (e.g. air turbines and ultrasonic scalers) to hand instruments. Moreover, many practices have been outfitted with air purification systems to improve ventilation within the building.
Some practice owners have gone a step further by investing in digital technology that can facilitate a complete in-house restorative workflow. Intraoral scanning and chairside manufacturing systems, for example, eliminate the need for traditional impression-taking techniques and referrals to a dental laboratory. This can reduce cross-infection risks, as there is minimal handling involved in the process of taking digital impressions and producing restorations in practice.
Through virtual consultations and remote treatment monitoring, dental professionals have also been able to reduce the number of patients in the practice at any one time, which can help further minimise the chances of an infection being transmitted. To enable patients to attend their dental appointments, practices have been redesigned to facilitate social distancing, with hand sanitisers made readily available and rigorous screening for COVID-19 – including temperature checks – carried out before anyone even enters the building. Contactless payment methods ensure further peace-of-mind among both staff and patients.
It is clear that great strides have been made to protect everyone in the dental care setting over the course of the COVID-19 pandemic, but there is always more that can be done. Being able to quickly and effectively screen your workforce for COVID-19 antibodies can enable better informed decision-making with regards to getting team members back to work. This makes the BioSURE® COVID-19 Triple Antibody Rapid Test a true game changer for dental professionals seeking a means to differentiate between symptoms of COVID-19 and those of the common cold or flu.
The BioSURE® COVID-19 Triple Antibody Rapid Test is a single use, in vitro diagnostic test for the qualitative detection of immunoglobulin A, G and M (IgA, IgG and IgM) antibodies to COVID-19 in human whole blood (finger prick or venous), serum or plasma. With 98.3% sensitivity and 98.8% specificity, it is simple to perform and does not require any additional equipment – only 5ul of capillary blood is needed to receive results in just 10 minutes. This test is also CE marked for professional use only and registered with the Medicines and Healthcare products Regulatory Agency (MHRA).
Developed and manufactured in its entirety in the UK, the BioSURE® COVID-19 Triple Antibody Rapid Test comes in a box containing sufficient product for 25 tests, which must only be carried out by a dentist or another suitably qualified dental professional. You can take full advantage of this innovative solution by ensuring safe, quick and seamless staff testing with the help of leading oral health specialist, Curaden. In addition to supplying you with the test itself, Curaden can assist you in training your screening staff and creating a socially distanced screening area in your practice. The team can also support you with high-quality PPE, educational resources and reporting tools in the form of the BioSURE® powered by PocDoc app.
The unique security features of the BioSURE® powered by PocDoc app enables each test to be connected to a specific individual without the need for their personal data, thus providing full traceability without breaching individual privacy. Furthermore, this app can aggregate full working reports containing critical data points that can be used to assess workforce health and COVID-19 safety across multiple practices and over extended periods of time, if required. The app can also recommend key steps in terms of continued workforce testing and protection in order to support health and safety due diligence.
Building an accurate picture of overall workforce health enables dental practices to plan more efficiently and make better informed decisions about staff, especially during the cold and flu season. This emphasises the importance of the BioSURE® COVID-19 Triple Antibody Rapid Test as an essential diagnostic tool that can support vital sectors such as dentistry in continuing to work safely and effectively under the challenges of a global pandemic. To order a 25-pack of these game-changing COVID-19 antibody tests – priced at £750 excluding VAT –
Author: Richard Thomas CEO Curaprox UK LTD
No comments yet.
Sorry, the comment form is closed at this time.